Trademarkia Logo

Canada

C$
ADRESTIA
ABANDONED SECTION 36

on 10 Jul 2024

Last Applicant/ Owned by

ADRESTIA THERAPEUTICS LTD

Moneta Building,280 Babraham Research Campus,BabrahamCambridge CB22 3AT

GB

Serial Number

2094431 filed on 8th Dec 2020

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

ADRESTIA

Trademark usage description

chemicals used in science; biological preparations for use in science; biochemicals for research use; cell lines and bio-production cell lines for sci Read More

Classification Information


Class [001]
Chemicals used in science; biological preparations for use in science; biochemicals for research use; cell lines and bio-production cell lines for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, in the nature of biological and biochemical reagents; biological and chemical reagents for research use; chemical reagents; protein [raw material]; gene extracts for research purposes; chemicals and biochemicals for drug discovery, lead identification, diagnostics, profiling and research.


Classification kind code

11

Class [005]
Medical and veterinary preparations; pharmaceutical substances and preparations for human use; biopharmaceutical substances and preparations for human use; reagents, diagnostics and therapeutic preparations; biological preparations for medical purposes; medical preparations for use in gene therapy; diagnostic preparations; small molecules for therapeutic and diagnostic use; genomic samples for medical laboratory use.


Classification kind code

11

Class [035]
Advertising, marketing, promotional and business


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Medical, scientific and industrial research services; pharmaceutical and biopharmaceutical research and development services; medical and pharmacological research services; examination and testing of genes; development, examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, examination and testing of medicaments; the development of test systems for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of gene banks; research and development services in the creation of libraries or collections of biologicals, genetic material, genetic information, chemicals and compounds; providing biological or medical information for use in research; providing biological or medical information for use in medical research for monitoring health and disease; providing scientific research information and data in relation to health and disease state; research into personalised medicine; research services in the field of personalised diagnostics, research services in the field of personal medical profiles; provision of scientific research information in the field of personalised medicine; pharmaceutical drug development services; consultancy and advisory relating to all the aforesaid services.


Classification kind code

11

Class [044]
Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others; providing personalised medicine services and personalised medical diagnostic services; personal medical information; provision of medical information; provision of information to enable human diagnosis; providing medical information to enable the monitoring of patients; providing medical information to enable the assessment of progress in disease and treatment; consultancy and advisory relating to all the aforesaid services.


Classification kind code

11

Mark Details


Serial Number

2094431

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 15th Jul 2022
Search Recorded
Submitted for opposition 20
on 15th Jul 2022
Examiner's First Report
Submitted for opposition 223
on 15th Jul 2022
Total Provisional Refusal
Submitted for opposition 135
on 26th May 2022
Amendment to Application
Submitted for opposition 256
on 25th Jan 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 25th Mar 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 24th Mar 2021
Created
Submitted for opposition 31
on 24th Mar 2021
Formalized
Submitted for opposition 30
on 8th Dec 2020
Filed
Submitted for opposition 228
on 8th Dec 2020
International Registration